Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors and Prognosis of Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT07433205 is registered in ClinicalTrials.gov with First Affiliated Hospital of Chongqing Medical University as lead sponsor.

NCT NCT07433205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07433205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors and Prognosis of Metabolic Dysfunction-Associated Steatotic Liver Disease
Lead sponsor
First Affiliated Hospital of Chongqing Medical University
Phase
Observational
Overall status
Completed
Start date
January 1, 2024
Completion date
December 31, 2025
Enrollment
922 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated steatotic liver disease (masld)